申请人:——
公开号:US06177424B1
公开(公告)日:2001-01-23
The invention relates to 4′-substituted-4′,5′-dihydropsoralen compounds of formula(V):
In the formula R is hydrogen, a halogen, CN or an acyl group; T is a halogen, CN, a carboalkoxy group NR1R2, or (N+R1R2R3)X−, R1 and R2 are independently a C1-C6 alkyl, or R1 and R2 together with the nitrogen form a 5-8 member heterocyclic ring, or when T is (N+R1R2R3)X−, R1 and R2 together with the nitrogen form a 5-8 member heterocyclic ring or heterocyclic aromatic ring; R3 is hydrogen, a C1-C12 alkyl, or, when R1 and R2 together with the nitrogen form a heterocyclic aromatic ring, R3 is a double bond within the heterocyclic aromatic ring; X− is a halide. In another embodiment, the invention relates to processes for preparing 4′-substituted-4′,5′-dihydropsoralen compounds described above. The compounds of the invention have beneficial pharmaceutical properties and can be used alone or in pharmaceutical compositions used to treat a proliferative skin disorder and to treat microbial infections in a mammal by administering to the mammal an effective amount of a compound of the invention and then irradiating the mammal with ultraviolet light.
本发明涉及公式(V)的4'-取代-4',5'-二氢基香豆素化合物:在公式中,R为氢,卤素,CN或酰基基团;T为卤素,CN,羧基烷氧基基团NR1R2或(N+R1R2R3)X−,R1和R2分别为C1-C6烷基,或者R1和R2与氮一起形成5-8成员杂环环,或者当T为(N+R1R2R3)X−时,R1和R2与氮一起形成5-8成员杂环环或杂环芳香环;R3为氢,C1-C12烷基,或者当R1和R2与氮一起形成杂环芳香环时,R3为杂环芳香环内的双键;X−为卤化物。在另一实施例中,本发明涉及制备上述4'-取代-4',5'-二氢基香豆素化合物的过程。本发明的化合物具有有益的药理学性质,可以单独使用或与药物组合物一起使用,用于治疗增生性皮肤疾病,并通过给哺乳动物施加有效量的本发明化合物,然后照射哺乳动物的紫外线来治疗微生物感染。